---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003751"
form_type: "8-K/A"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:20:31.626940+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Evofem amends prior 8-K to fix exhibit link for Series F-1 Preferred Stock certificate

## Summary
- Filing corrects reference to Certificate of Designation of Series F-1 Preferred Stock.
- Original merger agreement with Aditxt reported on Dec 27, 2023 remains unchanged.
- No financial impact or change to merger terms from this technical amendment.
- Exhibit 3.1 now properly incorporated by reference to Dec 12, 2023 8-K.

## SEC filing metadata
- accession: 0001493152-24-003751
- form_type: 8-K/A
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315224003751/0001493152-24-003751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315224003751/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003751
- JSON: https://secwatch.observer/filing/0001493152-24-003751.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003751.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.